Sudden Cardiac Death

Compared with patients on dialysis who received amoxicillin-based treatment, those who received azithromycin treatment were at an increased risk for sudden cardiac death, according to data published in Kidney Medicine.

Young people with schizophrenia had elevated risk for sudden cardiac death, and biopsychosocial factors related to social isolation impacted the cardiac risk factor burden in individuals with schizophrenia, researchers reported.

The American College of Cardiology Scientific Session featured three late-breaking clinical trials of particular interest to the sports cardiology and hypertrophic cardiomyopathy communities.

Income and education had an inverse relationship with the risk for sudden cardiac death that was not explained by modifiable risk factors, researchers reported.

Patients with heart failure who received an SGLT2 inhibitor were less likely to experience sudden cardiac death compared with those who received placebo, according to a study in Clinical Cardiology.

Health care provider interactions with family members after a relative’s sudden cardiac death vary in type, format and timing, and stress surrounding the event can affect relatives’ decisions to pursue genetic screenings, data show.

Healio and Cardiology Today have aggregated the top cardiology headlines of March 2023.

SGLT2 inhibitor therapy in patients with heart failure is associated with a significantly lower incidence of sudden cardiac death vs. placebo, with the benefit persisting independent of other guideline-directed medical therapies.

NEW ORLEANS — Elite athletes with genetic risk for sudden cardiac death can safely return to play with a shared decision-making model that includes careful evaluation, risk stratification and tailoring of genetic heart disease therapy.

Electronic gaming can precipitate lethal cardiac arrhythmias in children with proarrhythmic conditions, though worldwide incidence appears to be low overall, researchers reported.